NCT05717062: An ongoing trial by Ophirex, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05717062 |
|---|---|
| Title | Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subjects Bitten by Venomous Snakes |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 30, 2023 |
| Completion date | Nov. 28, 2024 |
| Required reporting date | Nov. 28, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |